DCT
2:15-cv-01455
Allergan Inc v. Teva Pharma USA Inc
General
Filed
08/24/15
Cause of ActionInfringement
SectorBiotech
Status
Closed (12/13/18)
Patent Owner
Operating Company (L)
PACER2:15-cv-01455
Appeals18-1130
CourtE.D. Texas
Judge | Period | PO Win Rate |
|---|---|---|
-- | 25% |
Plaintiff
Party
Name | Ratings |
|---|---|
L5E | |
L5E | |
---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5A | |
L5C | |
L4A | |
L4A | |
L4A | |
L4C | |
L4C | |
L4C | |
L2C | |
L5E | |
L5B | |
L5E | |
L4E | |
L3D | |
L2E | |
L5E | |
L4E |
Defendant
Party
Name | Ratings |
|---|---|
L5E | |
L5A | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L2D | |
L1C | |
L1C | |
L1D |
Attorney
Name | Ratings |
|---|---|
Gillam & Smith LLPLocal | L5A |
L5A | |
L5A | |
L5A | |
L5E | |
L5E | |
L4C | |
L3B | |
L2D | |
---- -- | |
---- -- | |
Potter MintonLocal | L5A |
L4B | |
L5B | |
L4B | |
L3B | |
L4A | |
L4B | |
L2B | |
Findlay CraftLocal | L4A |
L1B | |
L4B | |
L5B | |
L5B | |
L5B | |
L5E | |
L4D | |
L5E | |
Dacus FirmLocal | L3B |
L1B | |
L3C | |
L5A | |
L5C | |
L5E | |
L4C | |
L1-- -- | |
L3E | |
L5E | |
L4D | |
L3E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4D | |
L4E | |
---- -- | |
L2C | |
L1B | |
L2D | |
L5B | |
L5B | |
L1-- -- | |
L2E | |
L4B | |
L2A | |
L2C | |
L1B | |
L2E | |
L5D | |
L5E | |
L4D | |
L4E | |
L1E | |
L5E |